You searched for "diabetes"
Artificial intelligence and oculomics: Improving global health
2 June 2025
| Charles Cleland, Elliott Taylor
|
EYE - Imaging
The application of artificial intelligence (AI), and in particular deep learning, to high-resolution ocular imaging has led to many new discoveries, enabling the prediction of multiple different systemic diseases from ocular biomarkers. This emerging field is known as ‘oculomics’ [1]....
Situation analysis of diabetic retinopathy services in eleven countries
1 December 2015
| Peter Blows, Tunde Peto, Heiko Philippin, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A five-year project funded by The Queen Elizabeth Diamond Jubilee Trust is facilitating development of diabetic retinopathy services (DRS) to reduce unnecessary blindness in 10 Commonwealth countries through the establishment of a capacity-building network, the DR-NET part of the Commonwealth...
Understanding the inequalities of ophthalmic care for Indigenous people in a first world country
Aboriginal Australians have faced numerous challenges over the past centuries. Here in this article, Edward Saxton highlights why there are inequalities of ophthalmic care in Australia and why this has led to increased levels of blindness in Aboriginal people relative...Clinical Applications of Optical Coherence Tomography Angiography
Clinical Applications of Optical Coherence Tomography Angiography provides an informative, up-to-date review of the numerous applications of OCTA in ophthalmology. This book highlights the ways in which this relatively recent non-invasive imaging technique has been an invaluable tool for our...Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders
3 February 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...
Ocular hypertension following intravitreal steroid injections: a comparative study between triamcinolone-acetonide and dexamethasone-implant
This was a retrospective observational study of steroid response following 1549 intravitreal steroid (TA and Dex) injections. One thousand and seventy-five eyes of 897 patients were reviewed. Glaucoma patients, glaucoma suspects, uveitis, trauma, and cases with less than one month...A life outside ophthalmology
3 April 2023
| Katie Curran, Lloyd Paul Aiello (Prof), Tunde Peto
|
EYE - General
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...
Avastin vs. Volon A for diabetic macular oedema
1 June 2014
| Nana Theodorou
|
EYE - Vitreo-Retinal
This prospective randomised interventional clinical trial compared 30 diabetic patients with macular oedema treated with either intravitreal injections of bevacizumab (Avastin) or triamcinolone (Volon A). One group initially received three injections of 2.5 mg Avastin in monthly intervals whilst the...
Building capacity in eye health: A story of partnerships and collaborations
4 December 2024
| Shaffi Mdala, Covadonga Bascaran
|
EYE - Vitreo-Retinal
In the evolving landscape of global eye health, partnerships and collaborations have been instrumental in driving capacity building and professional development. The impact of strategic alliances like VISION 2020 LINKS and the Diabetic Retinopathy Network (DR-NET) cannot be overstated, as...
Artificial intelligence in eyecare: how do we ensure new technologies truly benefit our patients?
3 April 2023
| Fiona Buckmaster
|
EYE - General
From monitoring patients with heart disease to improving the early diagnosis of cancer, artificial intelligence (AI) using deep learning techniques is already employed in many different healthcare specialties [1]. In the eyecare field, AI technologies have been used to analyse...
DR-NET Workshop – information-sharing for strengthening DR programmes
1 October 2021
| Onyinye Onyia, Covadonga Bascaran, Marcia Zondervan
|
EYE - Vitreo-Retinal, EYE - General
Contributors: Rosie Brennan, Anshul Chauhan, Mona Duggal, John Ellis, Michael Gichangi, Edwin Grayson, Catherine Jamieson, Ankita Kankaria, Oliver Kemp, Hendra Kusuma, Nanda Matthew, Geeta Menon, Habibah Muhiddin, Tunde Peto, Recivall Salongcay, Frank Sandi, Hazel Shillingford-Ricketts, Bernadetha Shilio, Caroline Styles, Sharon...
Why Ophthalmology?
13 December 2023
| Jonathan YM Lai
|
EYE - General
Ophthalmology is a medical specialty that deals with eye diseases and helps preserve vision. The ophthalmic community consists of a wide range of healthcare professionals who work together to address eye-related problems in many extraordinary ways. This article explores the...